查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1710831

全球消化二胺氧化酶补充剂市场规模研究（按成分、最终剂型和区域预测，2022-2032 年）

Global Digestive Diamine Oxidase Enzyme for Supplements Market Size study, by Ingredient, Final Dosage Form, and Regional Forecasts 2022-2032
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 285 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023 年全球消化二胺氧化酶补充剂市场价值约为 238 亿美元，预计在 2024-2032 年预测期内将以超过 5.64% 的复合年增长率增长。二胺氧化酶 (DAO) 补充剂已成为解决组织胺不耐受和相关消化失衡的重要饮食解决方案。随着全球人口越来越关注肠道健康和全身炎症，DAO 在缓解胃肠不适、偏头痛和食物敏感症状方面的治疗潜力正在推动其在补充剂领域的迅速应用。市场参与者正在将 DAO 策略性地定位在清洁标籤营养保健品中，目标是那些积极寻求针对慢性消化不适的针对性酵素干预措施的健康意识消费者。

推动这一成长的因素有很多：功能性食品消费的急剧上升、个人化营养平台的扩展以及消费者越来越注重整体健康习惯。 DAO 在补充剂中的应用，特别是片剂、胶囊和粉末形式的应用，由于科学依据和组胺相关消化系统疾病的日益普及而扩大。酵素稳定和封装技术的进步使得生物利用度和货架稳定性更高，进一步增强了 DAO 注入配方的商业可行性。同时，主要市场的监管明确性以及 DAO 在医生主导的治疗方案中的日益普及为更广泛的临床认可奠定了基础。

然而，市场并非没有摩擦点。消费者对 DAO 在组胺分解中的具体作用的认识有限，尤其是在发展中经济体，这仍然是一个瓶颈。高生产成本以及复杂的提取和净化协议也限制了可扩展性。此外，来自通用消化酶混合物的竞争以及 DAO 相关研究的新兴状态继续带来策略风险。然而，这些挑战正在催化创新，为植物酶替代品、符合素食主义的配方以及将 DAO 与益生菌和抗炎化合物协同作用的辅酶混合物铺平道路。

将 DAO 酶整合到针对肠脑轴健康、皮肤活力和代谢和谐的多效益健康补充剂中，正在开闢前所未有的商业途径。有影响力的品牌故事和直接面向消费者的分销模式正在重塑竞争格局，特别是在数位化消费者的市场中。营养保健品製造商也与临床研究人员合作，利用脂质体和延迟释放技术设计生物可利用的 DAO 传输机制。生物技术和消费者趋势的融合增强了 DAO 对各个年龄层的吸引力，尤其是对易受组织胺敏感性影响的女性和老年人群。

从地区来看，北美引领全球 DAO 补充剂市场，这得益于强劲的膳食补充剂消费、较高的消费者健康素养以及强大的电子商务渗透率。欧洲紧随其后，其营养基因组学应用不断增长，标籤标准也越来越有利。同时，由于可支配收入的增加、对预防性医疗保健的兴趣的增加以及中国、日本和印度等国家健康产业的蓬勃发展，预计亚太地区将出现最快的增长。随着当地生产能力的提高和健康教育活动的开展，人们对酵素疗法的认识也不断提高，拉丁美洲和中东及非洲也将稳步增长。

目录

第一章：全球消化二胺氧化酶补充剂市场执行摘要

  • 全球 DAO 补充剂市场规模和预测（2022-2032 年）
  • 区域概要
  • 节段总结
    • 按成分
    • 按最终剂型
  • 主要趋势
  • 监管影响
  • 分析师建议与结论

第 2 章：全球 DAO 补充剂市场定义与研究假设

  • 研究目标
  • 市场定义
  • 研究假设
    • 包容与排斥
    • 限制
    • 供给侧分析
      • DAO 资源的可用性
      • 处理基础设施
      • 监管环境
      • 竞争格局
      • 成本动态
    • 需求面分析
      • 消费者健康意识
      • 分销管道
      • 技术创新
      • 医师和执业医师的采用
  • 估算方法
  • 研究考虑的年份
  • 货币兑换率

第三章：全球 DAO 补充品市场动态

  • 市场驱动因素
    • 人们对组织胺不耐受和肠道健康的认识不断提高
    • 功能性营养和个人化营养激增
    • 酶稳定和输送技术的进展
  • 市场挑战
    • 新兴地区消费者知识有限
    • 开采和生产成本高
    • 来自通用消化酵素混合物的竞争
  • 市场机会
    • 植物基和纯素DAO替代品的开发
    • 益生菌和抗发炎活性成分的复合配方
    • 融入数位健康和​​远端营养平台

第 4 章：全球 DAO 补充剂市场产业分析

  • 波特五力模型
    • 供应商的议价能力
    • 买家的议价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争对手
  • PESTEL分析
    • 政治的
    • 经济的
    • 社会的
    • 科技
    • 环境的
    • 合法的
  • 最佳投资机会
  • 最佳获胜策略
  • 颠覆性趋势
  • 产业专家观点
  • 分析师建议与结论

第 5 章：全球 DAO 补充剂市场规模和预测：按成分划分，- 2022-2032 年

  • 细分仪表板
  • 全球 DAO 市场：成分收入趋势分析（2022 年和 2032 年）
    • 植物性二胺氧化酶
    • 动物源二胺氧化酶

第六章：全球 DAO 补充品市场规模与预测：以最终剂型划分，2022 年至 2032 年

  • 细分仪表板
  • 全球 DAO 市场：剂型收入趋势分析（2022 年和 2032 年）
    • 平板电脑
    • 胶囊
    • 粉末
    • 其他的

第 7 章：全球 DAO 补充剂市场规模和预测：按地区，- 2022-2032 年

  • 北美DAO补充剂市场
    • 美国DAO补充剂市场
    • 加拿大DAO补充剂市场
  • 欧洲DAO补充剂市场
    • 英国DAO补充剂市场
    • 德国DAO补充剂市场
    • 法国DAO补充剂市场
    • 西班牙DAO补充剂市场
    • 义大利DAO补充剂市场
    • 欧洲其他地区DAO补充剂市场
  • 亚太地区DAO补充剂市场
    • 中国DAO补充剂市场
    • 印度DAO补充剂市场
    • 日本DAO补充剂市场
    • 澳洲DAO补充剂市场
    • 韩国DAO补充剂市场
    • 亚太其他地区DAO补充品市场
  • 拉丁美洲DAO补充市场
    • 巴西DAO补充剂市场
    • 墨西哥DAO补充剂市场
    • 拉丁美洲其他地区的DAO补充市场
  • 中东和非洲 DAO 补充品市场
    • 沙乌地阿拉伯DAO补充剂市场
    • 南非DAO补充剂市场
    • 中东和非洲其他地区的 DAO 补充市场

第 8 章：竞争情报

  • 重点公司 SWOT 分析
    • Swanson Health Products
    • NOW Foods
    • Biotech Pharmacal Inc.
  • 顶级市场策略
  • 公司简介
    • Swanson Health Products
      • 关键讯息
      • 概述
      • 财务（视数据可用性而定）
      • 产品概要
      • 市场策略
    • NOW Foods
    • Biotech Pharmacal Inc.
    • Jarrow Formulas, Inc.
    • SFI Health
    • Xymogen
    • Integrative Therapeutics, LLC
    • Seeking Health
    • Pure Encapsulations, LLC
    • Nutricology Inc.
    • Kirkman Group Inc.
    • Life Extension Foundation
    • Ambe Phytoextracts Pvt. Ltd.
    • Enzymotec Ltd.
    • Natural Factors Nutritional Products Ltd.

第九章：研究过程

  • 研究过程
    • 资料探勘
    • 分析
    • 市场评估
    • 验证
    • 出版
  • 研究属性
简介目录

Global Digestive Diamine Oxidase Enzyme for Supplements Market is valued at approximately USD 23.8 billion in 2023 and is anticipated to grow with a compelling CAGR of more than 5.64% over the forecast period 2024-2032. Diamine oxidase (DAO) enzyme supplementation has emerged as a crucial dietary solution to address histamine intolerance and related digestive imbalances. As the global population becomes increasingly aware of gut health and systemic inflammation, DAO's therapeutic potential in mitigating gastrointestinal distress, migraines, and food sensitivity symptoms is driving its swift adoption in the supplements space. Market players are strategically positioning DAO within clean-label nutraceuticals, targeting health-conscious consumers actively seeking targeted enzymatic interventions for chronic digestive discomfort.

Fueling this surge is a confluence of factors: the dramatic uptick in functional food consumption, the expansion of personalized nutrition platforms, and the broader consumer shift toward holistic wellness routines. DAO's application in supplements, particularly in tablet, capsule, and powder forms, is being amplified by scientific backing and the growing visibility of histamine-related digestive disorders. Technological progress in enzyme stabilization and encapsulation is enabling higher bioavailability and shelf stability, further enhancing the commercial viability of DAO-infused formulations. Concurrently, regulatory clarity in major markets and rising inclusion of DAO in practitioner-led treatment regimens are setting the stage for broader clinical endorsement.

However, the market is not without friction points. Limited consumer awareness regarding DAO's specific role in histamine breakdown, especially in developing economies, remains a bottleneck. High production costs, along with complex extraction and purification protocols, also limit scalability. Moreover, competition from generic digestive enzyme blends and the nascent state of DAO-related research continue to pose strategic risks. Yet, these challenges are catalyzing innovation-paving the way for plant-based enzyme alternatives, vegan-compliant formulations, and co-enzymatic blends that synergize DAO with probiotics and anti-inflammatory compounds.

The integration of DAO enzymes into multi-benefit wellness supplements tailored for gut-brain axis health, skin vitality, and metabolic harmony is unlocking unprecedented commercial pathways. Influencer-led brand storytelling and direct-to-consumer distribution models are reshaping the competitive landscape, particularly in markets with digitally engaged consumers. Nutraceutical manufacturers are also collaborating with clinical researchers to design bioavailable DAO delivery mechanisms using liposomal and delayed-release technologies. This convergence of biotech and consumer trends is amplifying DAO's appeal across age groups, particularly among women and aging populations susceptible to histamine sensitivity.

Regionally, North America leads the global DAO supplements market, driven by robust dietary supplement consumption, high consumer health literacy, and strong e-commerce penetration. Europe follows closely with rising nutrigenomic applications and favorable labeling standards. Meanwhile, Asia Pacific is expected to witness the fastest growth due to increasing disposable income, greater interest in preventive healthcare, and a burgeoning wellness industry in countries such as China, Japan, and India. Latin America and the Middle East & Africa are also poised for steady growth as local production capabilities improve and health education initiatives spread awareness about enzyme-based therapies.

Major market player included in this report are:

  • Swanson Health Products
  • NOW Foods
  • Biotech Pharmacal Inc.
  • Jarrow Formulas, Inc.
  • SFI Health
  • Xymogen
  • Integrative Therapeutics, LLC
  • Seeking Health
  • Pure Encapsulations, LLC
  • Nutricology Inc.
  • Kirkman Group Inc.
  • Life Extension Foundation
  • Ambe Phytoextracts Pvt. Ltd.
  • Enzymotec Ltd.
  • Natural Factors Nutritional Products Ltd.

The detailed segments and sub-segment of the market are explained below:

By Ingredient

  • Plant-Based Diamine Oxidase
  • Animal-Based Diamine Oxidase

By Final Dosage Form

  • Tablets
  • Capsules
  • Powders
  • Others

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Years considered for the study are as follows:

  • Historical year - 2022
  • Base year - 2023
  • Forecast period - 2024 to 2032

Key Takeaways:

  • Market Estimates & Forecast for 10 years from 2022 to 2032.
  • Annualized revenues and regional level analysis for each market segment.
  • Detailed analysis of geographical landscape with country-level analysis of major regions.
  • Competitive landscape with information on major players in the market.
  • Analysis of key business strategies and recommendations on future market approach.
  • Analysis of competitive structure of the market.
  • Demand side and supply side analysis of the market.

Table of Contents

Chapter 1. Global Digestive Diamine Oxidase Enzyme for Supplements Market Executive Summary

  • 1.1. Global Digestive Diamine Oxidase Enzyme for Supplements Size & Forecast (2022-2032)
  • 1.2. Regional Summary
  • 1.3. Segmental Summary
    • 1.3.1. By Ingredient
    • 1.3.2. By Final Dosage Form
  • 1.4. Key Trends
  • 1.5. Regulatory Impact
  • 1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Digestive Diamine Oxidase Enzyme for Supplements Definition and Research Assumptions

  • 2.1. Research Objective
  • 2.2. Market Definition
  • 2.3. Research Assumptions
    • 2.3.1. Inclusion & Exclusion
    • 2.3.2. Limitations
    • 2.3.3. Supply Side Analysis
      • 2.3.3.1. Availability of DAO Sources
      • 2.3.3.2. Processing Infrastructure
      • 2.3.3.3. Regulatory Environment
      • 2.3.3.4. Competitive Landscape
      • 2.3.3.5. Cost Dynamics
    • 2.3.4. Demand Side Analysis
      • 2.3.4.1. Consumer Health Awareness
      • 2.3.4.2. Distribution Channels
      • 2.3.4.3. Technological Innovations
      • 2.3.4.4. Physician & Practitioner Adoption
  • 2.4. Estimation Methodology
  • 2.5. Years Considered for the Study
  • 2.6. Currency Conversion Rates

Chapter 3. Global Digestive Diamine Oxidase Enzyme for Supplements Dynamics

  • 3.1. Market Drivers
    • 3.1.1. Growing Awareness of Histamine Intolerance and Gut Health
    • 3.1.2. Surge in Functional & Personalized Nutrition
    • 3.1.3. Advances in Enzyme Stabilization and Delivery Technology
  • 3.2. Market Challenges
    • 3.2.1. Limited Consumer Knowledge in Emerging Regions
    • 3.2.2. High Extraction and Production Costs
    • 3.2.3. Competition from Generic Digestive Enzyme Blends
  • 3.3. Market Opportunities
    • 3.3.1. Development of Plant Based and Vegan DAO Alternatives
    • 3.3.2. Co formulation with Probiotics and Anti inflammatory Actives
    • 3.3.3. Integration into Digital Health & Tele nutritional Platforms

Chapter 4. Global Digestive Diamine Oxidase Enzyme for Supplements Industry Analysis

  • 4.1. Porter's Five Forces Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. PESTEL Analysis
    • 4.2.1. Political
    • 4.2.2. Economic
    • 4.2.3. Social
    • 4.2.4. Technological
    • 4.2.5. Environmental
    • 4.2.6. Legal
  • 4.3. Top Investment Opportunities
  • 4.4. Top Winning Strategies
  • 4.5. Disruptive Trends
  • 4.6. Industry Expert Perspective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Digestive Diamine Oxidase Enzyme for Supplements Size & Forecast by Ingredient, 2022-2032

  • 5.1. Segment Dashboard
  • 5.2. Global DAO Market: Ingredient Revenue Trend Analysis (2022 & 2032)
    • 5.2.1. Plant Based Diamine Oxidase
    • 5.2.2. Animal Based Diamine Oxidase

Chapter 6. Global Digestive Diamine Oxidase Enzyme for Supplements Size & Forecast by Final Dosage Form, 2022-2032

  • 6.1. Segment Dashboard
  • 6.2. Global DAO Market: Dosage Form Revenue Trend Analysis (2022 & 2032)
    • 6.2.1. Tablets
    • 6.2.2. Capsules
    • 6.2.3. Powders
    • 6.2.4. Others

Chapter 7. Global Digestive Diamine Oxidase Enzyme for Supplements Size & Forecast by Region, 2022-2032

  • 7.1. North America Digestive Diamine Oxidase Enzyme for Supplements
    • 7.1.1. U.S. Digestive Diamine Oxidase Enzyme for Supplements
    • 7.1.2. Canada Digestive Diamine Oxidase Enzyme for Supplements
  • 7.2. Europe Digestive Diamine Oxidase Enzyme for Supplements
    • 7.2.1. UK Digestive Diamine Oxidase Enzyme for Supplements
    • 7.2.2. Germany Digestive Diamine Oxidase Enzyme for Supplements
    • 7.2.3. France Digestive Diamine Oxidase Enzyme for Supplements
    • 7.2.4. Spain Digestive Diamine Oxidase Enzyme for Supplements
    • 7.2.5. Italy Digestive Diamine Oxidase Enzyme for Supplements
    • 7.2.6. Rest of Europe Digestive Diamine Oxidase Enzyme for Supplements
  • 7.3. Asia Pacific Digestive Diamine Oxidase Enzyme for Supplements
    • 7.3.1. China Digestive Diamine Oxidase Enzyme for Supplements
    • 7.3.2. India Digestive Diamine Oxidase Enzyme for Supplements
    • 7.3.3. Japan Digestive Diamine Oxidase Enzyme for Supplements
    • 7.3.4. Australia Digestive Diamine Oxidase Enzyme for Supplements
    • 7.3.5. South Korea Digestive Diamine Oxidase Enzyme for Supplements
    • 7.3.6. Rest of Asia Pacific Digestive Diamine Oxidase Enzyme for Supplements
  • 7.4. Latin America Digestive Diamine Oxidase Enzyme for Supplements
    • 7.4.1. Brazil Digestive Diamine Oxidase Enzyme for Supplements
    • 7.4.2. Mexico Digestive Diamine Oxidase Enzyme for Supplements
    • 7.4.3. Rest of Latin America Digestive Diamine Oxidase Enzyme for Supplements
  • 7.5. Middle East & Africa Digestive Diamine Oxidase Enzyme for Supplements
    • 7.5.1. Saudi Arabia Digestive Diamine Oxidase Enzyme for Supplements
    • 7.5.2. South Africa Digestive Diamine Oxidase Enzyme for Supplements
    • 7.5.3. Rest of Middle East & Africa Digestive Diamine Oxidase Enzyme for Supplements

Chapter 8. Competitive Intelligence

  • 8.1. Key Company SWOT Analysis
    • 8.1.1. Swanson Health Products
    • 8.1.2. NOW Foods
    • 8.1.3. Biotech Pharmacal Inc.
  • 8.2. Top Market Strategies
  • 8.3. Company Profiles
    • 8.3.1. Swanson Health Products
      • 8.3.1.1. Key Information
      • 8.3.1.2. Overview
      • 8.3.1.3. Financial (Subject to Data Availability)
      • 8.3.1.4. Product Summary
      • 8.3.1.5. Market Strategies
    • 8.3.2. NOW Foods
    • 8.3.3. Biotech Pharmacal Inc.
    • 8.3.4. Jarrow Formulas, Inc.
    • 8.3.5. SFI Health
    • 8.3.6. Xymogen
    • 8.3.7. Integrative Therapeutics, LLC
    • 8.3.8. Seeking Health
    • 8.3.9. Pure Encapsulations, LLC
    • 8.3.10. Nutricology Inc.
    • 8.3.11. Kirkman Group Inc.
    • 8.3.12. Life Extension Foundation
    • 8.3.13. Ambe Phytoextracts Pvt. Ltd.
    • 8.3.14. Enzymotec Ltd.
    • 8.3.15. Natural Factors Nutritional Products Ltd.

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes